On the contrary, a decrease in ACE2 levels is associated with an increase in pulmonary vascular permeability, pulmonary edema, ARDS, atherosclerosis, hypertension, cardiac hypertrophy, ventricular remodeling, and heart failure. The gene discussed is ACE2; the disease is Hypertension.